ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) Earnings History
Annual and quarterly earnings data from 2016 to 2024
Loading earnings history...
AAPG EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
AAPG Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | 97.0% | -37.7% | -41.3% |
| 2023 | 86.2% | -393.1% | -417.0% |
| 2022 | 89.5% | -405.2% | -421.0% |
| 2021 | 88.1% | -3116.6% | -2803.4% |
| 2020 | 84.2% | -5332.9% | -5442.6% |
Download Data
Export AAPG earnings history in CSV or JSON format
Free sign-in required to download data
ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) Earnings Overview
As of May 8, 2026, ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) reported trailing twelve-month net income of -$1.52B, reflecting +89.8% year-over-year growth. The company earned $-4.45 per diluted share over the past four quarters, with a net profit margin of -41.3%.
Looking at the long-term picture, AAPG's historical earnings data spans multiple years. The company achieved its highest annual net income of -$108M in fiscal 2016.
ASCENTAGE PHARMA GROUP INTERNATIONAL is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including ABBV ($4.23B net income, 6.9% margin), BCAB (-$60M net income, -2980.3% margin), KYMR (-$315M net income, -794.4% margin), AAPG has room to improve margins relative to the peer group. Compare AAPG vs ABBV →
AAPG Earnings vs Peers
Earnings metrics vs comparable public companies
AAPG Historical Earnings Data (2016–2024)
9 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$405M | +56.2% | -$370M | $-1.34 | -41.3% | -37.7% |
| 2023 | -$926M | -4.8% | -$873M | $-13.12 | -417.0% | -393.1% |
| 2022 | -$883M | -12.8% | -$850M | $-13.40 | -421.0% | -405.2% |
| 2021 | -$782M | -15.5% | -$870M | $-12.28 | -2803.4% | -3116.6% |
| 2020 | -$678M | +54.2% | -$664M | $-12.56 | -5442.6% | -5332.9% |
| 2019 | -$1.48B | -328.8% | -$583M | $-28.01 | -10202.7% | -4014.9% |
| 2018 | -$345M | -191.4% | -$50M | $-6.67 | -5072.8% | -738.1% |
| 2017 | -$119M | -9.9% | -$131M | $-2.29 | -1872.9% | -2064.9% |
| 2016 | -$108M | - | -$115M | $-2.08 | -1406.5% | -1495.0% |
See AAPG's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs AAPG Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare AAPG vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonAAPG — Frequently Asked Questions
Quick answers to the most common questions about buying AAPG stock.
Is AAPG growing earnings?
AAPG EPS is $-4.45, with earnings growth accelerating to +89.8%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-1.5B.
What are AAPG's profit margins?
ASCENTAGE PHARMA GROUP INTERNATIONAL net margin is -41.3%, with operating margin at -37.7%. Below-average margins reflect competitive or cost pressures.
How consistent are AAPG's earnings?
AAPG earnings data spans 2016-2024. The accelerating earnings trend is +89.8% YoY. Historical data enables comparison across business cycles.